- S&P 500 Futures consolidate the previous day’s losses amid sluggish session.
- US CPI drops the most since January but YoY figures keep Fed taper on the table.
- Vaccine, stimulus optimism favor bulls during a quiet session ahead of China data dump.
S&P 500 Futures portrays a corrective pullback from the lowest since late August, flashed the previous day, during Wednesday’s Asian session.
The risk barometer dropped to the multi-day on Tuesday after the US Consumer Price Index (CPI) data for August confused markets.
The US CPI dropped the most since January on monthly basis to 0.3% versus 0.4% expected and 0.5% prior. The CPI ex Food & Energy also dropped below 0.3% expected and previous readings to 0.1% during August, marking the biggest fall in six months. Fed’s readiness to accept a bit higher inflation figures, terming it ‘transitory’, seems to be at the test with almost double YoY figures than the US central bank’s previous target range of near 2.0%.
Recently favoring the stock futures could be the hopes of faster vaccinations in the UK, Australia and the US. It was also observed that the World Health Organization (WHO) urges India for vaccine donation to African countries as the Asian nation overcomes the initial virus woes and has the world’s faster jabbing of late.
Furthermore, concerns surrounding US President Joe Biden’s six-pronged strategy and the US-China tussles, recently over Taiwan, add to the market’s indecision as traders await the key data, Industrial Production and Retail Sales for the dragon nation.
Amid these plays, the US 10-year Treasury yields dropped the most in a month on Tuesday, before recently recovering to 1.29%.
Moving on, a light calendar in the US ahead of Thursday’s Retail Sales and Friday’s Michigan Consumer Confidence may push the market players towards more qualitative catalysts for fresh impulse.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.